These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6319847)

  • 1. A simple sensitive radioreceptor assay for calcium antagonist drugs.
    Gould RJ; Murphy KM; Snyder SH
    Life Sci; 1983 Dec; 33(26):2665-72. PubMed ID: 6319847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioreceptor and high-performance liquid chromatographic assays for the calcium channel antagonist nitrendipine in serum.
    Janis RA; Krol GJ; Noe AJ; Pan M
    J Clin Pharmacol; 1983 Jul; 23(7):266-73. PubMed ID: 6886028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO; Carpenter CL; Greenberg DA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR; Goll A; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex.
    Schoemaker H; Langer SZ
    Eur J Pharmacol; 1985 May; 111(2):273-7. PubMed ID: 2410283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
    Lee HR; Roeske WR; Yamamura HI
    Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of a novel calcium channel antagonist, mepirodipine, in plasma by radioreceptor assay using (+)-[3H]PN 200-110.
    Yamada S; Matsuoka Y; Suzuki N; Sugimoto N; Kato Y; Kimura R
    Pharm Res; 1992 Sep; 9(9):1227-30. PubMed ID: 1329069
    [No Abstract]   [Full Text] [Related]  

  • 9. Solubilization and affinity labeling of a dihydropyridine binding site from skeletal muscle: effects of temperature and diltiazem on [3H]dihydropyridine binding to transverse tubules.
    Kirley TL; Schwartz A
    Biochem Biophys Res Commun; 1984 Aug; 123(1):41-9. PubMed ID: 6089800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
    Gould RJ; Murphy KM; Snyder SH
    Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]Nitrendipine binding to calcium channels in bovine and rat pituitary.
    Titeler M; De Souza EB; Kuhar MJ
    J Neurochem; 1985 Jun; 44(6):1955-8. PubMed ID: 2580956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.
    Bristow MR; Ginsburg R; Laser JA; McAuley BJ; Minobe W
    Br J Pharmacol; 1984 Jun; 82(2):309-20. PubMed ID: 6329392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma.
    Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F
    Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors.
    Motulsky HJ; Snavely MD; Hughes RJ; Insel PA
    Circ Res; 1983 Feb; 52(2):226-31. PubMed ID: 6297831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The measurement of free nitrendipine in human serum by an equilibrium dialysis - radioreceptor assay.
    Lee HR; Roeske WR; Yamamura HI
    Life Sci; 1983 Oct; 33(18):1821-9. PubMed ID: 6645780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyridine binding sites regulate calcium influx through specific voltage-sensitive calcium channels in cerebellar granule cells.
    Carboni E; Wojcik WJ
    J Neurochem; 1988 Apr; 50(4):1279-86. PubMed ID: 2450173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
    Boles RG; Yamamura HI; Schoemaker H; Roeske WR
    J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unitary mechanism of calcium antagonist drug action.
    Murphy KM; Gould RJ; Largent BL; Snyder SH
    Proc Natl Acad Sci U S A; 1983 Feb; 80(3):860-4. PubMed ID: 6572372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of calcium-channel receptors in intact animals.
    Roeske WR; Lee HR; Yamamura HI; Schoemaker H
    Adv Myocardiol; 1985; 6():71-82. PubMed ID: 2986265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.